Radiotherapy for HIV patients: Are special precautions necessary?

Por Housri, Nadine, Yarchoan, Robert, Kaushal, Aradhana
Publicado em 2010

Treatment of Kaposi sarcoma herpesvirus-associated multicentric Castleman disease

Por Lurain, Kathryn, Yarchoan, Robert, Uldrick, Thomas S.
Publicado no Hematol Oncol Clin North Am (2018)

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome

Por Polizzotto, Mark N., Uldrick, Thomas S., Hu, Duosha, Yarchoan, Robert
Publicado em 2012

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome

Por Polizzotto, Mark N., Uldrick, Thomas S., Hu, Duosha, Yarchoan, Robert
Publicado no Front Microbiol (2017)

Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Contains Hypoxia Response Elements: Relevance to Lytic Induction by Hypoxia

Por Haque, Muzammel, Davis, David A., Wang, Victoria, Widmer, Isabelle, Yarchoan, Robert
Publicado em 2003

A Splenic Marginal Zone-Like Peripheral Blood CD27(+)B220(−) B Cell Population Is Preferentially Depleted in HIV Type 1-Infected Individuals

Por Morrow, Matthew, Valentin, Antonio, Little, Richard, Yarchoan, Robert, Pavlakis, George N.
Publicado em 2008

Cancer Prevention in HIV-Infected Populations

Por Goncalves, Priscila H., Montezuma-Rusca, Jairo M., Yarchoan, Robert, Uldrick, Thomas S.
Publicado no Semin Oncol (2015)

Genetic Organization and Hypoxic Activation of the Kaposi's Sarcoma-Associated Herpesvirus ORF34-37 Gene Cluster

Por Haque, Muzammel, Wang, Victoria, Davis, David A., Zheng, Zhi-Ming, Yarchoan, Robert
Publicado em 2006

Imaging Techniques for Kaposi Sarcoma (KS)

Por O’Mahony, Deirdre, Gandjbakhche, Amir H, Hassan, Moinuddin, Vogel, Abby, Yarchoan, Robert
Publicado em 2008

Characterization of the Activation of Protein Tyrosine Phosphatase, Receptor-Type, Z Polypeptide 1 (PTPRZ1) by Hypoxia Inducible Factor-2 Alpha

Por Wang, Victoria, Davis, David A., Veeranna, Ravindra P., Haque, Muzammel, Yarchoan, Robert
Publicado em 2010

Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induction by Hypoxia and Hypoxia-Inducible Factors

Por Veeranna, Ravindra P., Haque, Muzammel, Davis, David A., Yang, Min, Yarchoan, Robert
Publicado em 2012

Induction of KSHV latency-associated nuclear antigen (LANA) by hypoxia and hypoxia-inducible factors (HIF)

Por Veeranna, Ravindra P, Haque, Muzammel, Davis, David A, Yang, Min, Yarchoan, Robert
Publicado em 2012

Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children: Analysis of Cellular Immune Responses

Por Blazevic, Vesna, Jankelevich, Shirley, Steinberg, Seth M., Jacobsen, Freda, Yarchoan, Robert, Shearer, Gene M.
Publicado em 2001

Possible Therapeutic Vaccine Strategy against Human Immunodeficiency Virus Escape from Reverse Transcriptase Inhibitors Studied in HLA-A2 Transgenic Mice

Por Okazaki, Takahiro, Terabe, Masaki, Catanzaro, Andrew T., Pendleton, C. David, Yarchoan, Robert, Berzofsky, Jay A.
Publicado em 2006

Conserved Cysteines of the Human Immunodeficiency Virus Type 1 Protease Are Involved in Regulation of Polyprotein Processing and Viral Maturation of Immature Virions

Por Davis, David A., Yusa, Keisuke, Gillim, Laura A., Newcomb, Fonda M., Mitsuya, Hiroaki, Yarchoan, Robert
Publicado em 1999

Lack of Detection of Xenotropic Murine Leukemia Virus-Related Virus in HIV-1 Lymphoma Patients

Por Delviks-Frankenberry, Krista A., Chaipan, Chawaree, Bagni, Rachel, Wyvill, Kathleen, Yarchoan, Robert, Pathak, Vinay K.
Publicado em 2011

Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target IRAK1 and MYD88, Two Components of the Toll-Like Receptor/Interleukin-1R Signaling Cascade, To Reduce Inflammatory-Cytokine...

Por Abend, Johanna R., Ramalingam, Dhivya, Kieffer-Kwon, Philippe, Uldrick, Thomas S., Yarchoan, Robert, Ziegelbauer, Joseph M.
Publicado em 2012

Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma

Por Shrestha, Prabha, Davis, David A., Veeranna, Ravindra P., Carey, Robert F., Viollet, Coralie, Yarchoan, Robert
Publicado no PLoS Pathog (2017)

Identification of a Potential Pharmacological Sanctuary for HIV Type 1 in a Fraction of CD4(+) Primary Cells

Por Valentin, Antonio, Morrow, Matthew, Poirier, Richard H., Aleman, Karen, Little, Richard, Yarchoan, Robert, Pavlakis, George N.
Publicado em 2010

Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors against the Initial Autocleavage in Gag-Pol Polyprotein Processing

Por Davis, David A., Soule, Erin E., Davidoff, Katharine S., Daniels, Sarah I., Naiman, Nicole E., Yarchoan, Robert
Publicado em 2012